...
首页> 外文期刊>European journal of trauma: official publication of the European Trauma Society >Modulation of the Coagulation Cascade Using Recombinant Factor Vila and Activated Protein C in a Severely Injured Trauma Patient
【24h】

Modulation of the Coagulation Cascade Using Recombinant Factor Vila and Activated Protein C in a Severely Injured Trauma Patient

机译:在严重受伤的创伤患者中使用重组因子VIIa和活化的蛋白C调节凝血级联反应

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Exsanguination after trauma remains a leading cause of early death in severely injured patients [i]. Sepsis and multiple organ failure are significant causes of mortality in severely injured trauma patients who survive their injury and require a prolonged 1CLJ hospitalization [2]. Despite advances in operative technique and critical care medicine, the treatment options for patients with coagulopathic hemorrhage or severe sepsis have remained relatively unchanged. We report a unique case in which pharmacological modulators of coagulation, recombinant Factor Vila, and activated protein C were successfully used to treat massive hemorr-hage and then severe sepsis in a severely injured trauma patient.
机译:创伤后放血仍然是重伤患者早期死亡的主要原因[i]。脓毒症和多器官功能衰竭是严重受伤的创伤患者的重要死亡原因,这些患者要在损伤中幸存并需要长时间的1CLJ住院治疗[2]。尽管手术技术和重症监护医学有所进步,但对于凝血性出血或严重脓毒症的患者,治疗选择仍保持相对不变。我们报告了一个独特的案例,在该案例中,凝血,重组因子Vila和活化蛋白C的药理调节剂已成功用于治疗严重受伤的创伤患者的大量出血,然后发生严重败血症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号